IBM tests cancer diagnostic
October 24, 2013Medical Communications, Research and Development, Sales and Marketing Cancer, Zurich, ibm
IT giant IBM has teamed up with the University Hospital in Zurich to research a new oncology diagnostic test, in …
bmore creative appoints strategy director
October 24, 2013Medical Communications, Sales and Marketing bmore creative
Design, advertising and digital agency bmore creative has appointed Paul Haley to join its management team as a strategy director.Having …
Corruption probe hits GSK
October 24, 2013Sales and Marketing China, GSK, Q3, corruption
The fallout from corruption investigations in China has hit GlaxoSmithKline, which announced third quarter sales in the country were down …
Open access splits researchers
October 24, 2013Medical Communications, Research and Development, Sales and Marketing BMJ, open access, publishing, research
Small medical research charities are worried that the extra costs of open access publishing will have a significant impact on …
Horizon Discovery chairman steps down from Board
October 24, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing evans, horizon
Research tools firm Horizon Discovery has confirmed that David Evans has stepped down as chairman of its Board. Dr Ian …
Novartis sees profit slip
October 23, 2013Sales and Marketing Afinitor, Diovan, Novartis, Q3, gilenya
Novartis saw generic competition erode profit in the third quarter of the year, although sales across the group actually rose …
Sanofi launches ‘Monster Manor’ diabetes app
October 23, 2013Medical Communications Gamification, Sanofi, diabetes, monster manor
Sanofi has launched a new healthcare app called Monster Manor to help children with type 1 diabetes better manage their …
Indian pharma exports ‘set for 20% growth’ to 2018
October 23, 2013Manufacturing and Production API, CPhI, GMP, India, growth
Representatives of India’s pharma sector pledged to meet the government’s target of raising exports to $25 billion by 2016, as …
Reckitt Benckiser may shed pharma unit
October 23, 2013Sales and Marketing Reckitt Benckiser Pharmaceuticals, rbp, suboxone
Reckitt Benckiser Pharmaceuticals is considering selling its pharma unit within the next year after the recent loss of its biggest …
HGS founders join IMS Health team
October 23, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HGS, IMS Health, mcfarlane
Healthcare services firm IMS Health has appointed HGS Europe founders Graeme McFarlane and Angela McFarlane (pictured) to its UK team.
NICE ‘yes’ for Jetrea
October 23, 2013Sales and Marketing Jetrea, NHS, NICE, eye
Jetrea has completed its seemingly inexorable journey to NHS use in England and Wales for a rare eye condition following …
AZ begins late-stage trial of new cancer drug
October 22, 2013Research and Development, Sales and Marketing AstraZeneca, Cancer, NSCLC, selumetinib
AstraZeneca has begun a Phase III study for its investigational lung cancer pill selumetinib in patients with a genetic sub-type …
US regulator ponders Arzerra
October 22, 2013Sales and Marketing Arzerra, CLL, FDA, GSK
GlaxoSmithKline and Genmab have submitted their blood cancer drug Arzerra to the FDA as a first-line treatment for chronic lymphocytic …
Former GSK director joins Publicis Life Brands Resolute
October 22, 2013Manufacturing and Production, Research and Development, Sales and Marketing GSK, PLBR, publicis
Former director of branding and communications at GlaxoSmithKline Consumer Health Sian Dodwell, has joined Publicis Life Brands Resolute (PLBR) from …
Opsumit wins US approval
October 22, 2013Sales and Marketing actelion fda, opsumit
The FDA has approved Actelion’s oral endothelin receptor antagonist Opsumit as a treatment for pulmonary arterial hypertension (PAH), a potentially …
Effectively outsourcing medical and laboratory equipment procurement
October 21, 2013With Investigator Sites located across the World it is increasingly important to ensure that they all have the right equipment …
Ariad ditches CML trial
October 21, 2013Research and Development, Sales and Marketing Ariad, CML, iclusig
Ariad Pharmaceuticals has ditched its late-stage trial of Iclusig in patients with newly-diagnosed chronic myeloid leukemia (CML) after blood clots …
Eisai: reform NICE or we’ll pull out of the UK
October 21, 2013Research and Development, Sales and Marketing Eisai, Hatfield, Hunt, NICE
Eisai has criticised NICE for being too narrow minded on assessing new drugs, and has warned it may pull its …
No closer to Alzheimer’s cure despite rise in research
October 21, 2013Research and Development, Sales and Marketing Alzheimer's, depression, markram
A scientist charged with developing a digital model of the human brain has said that patients with neurological and neurodegenerative …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
